Arlevertan

Arlevertan appartiene a Hennig Arzneimittel GmbH & Co. KG, con sede in Germania. No. Il proprietario finale di Arlevertan, Hennig Arzneimittel GmbH & Co. KG, ha sede in Germania, non negli Stati Uniti.

Hennig Arzneimittel is an independent, family-owned German pharmaceutical company focusing on the research and production of medications for neurological and cardiovascular conditions.